What's New
They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better
Jan 8, 2024
Exploring the use of Ibogaine as a treatment for PTSD and depression in veterans, highlighting a study conducted by Stanford University and its significant positive outcomes. Ibogaine's potential in helping veterans with PTSD, anxiety disorders, and alcohol use disorder. The effects of ibogaine therapy on patients with PTSD and potential mechanisms for improving mental health. Calls for further research.
08:07
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Ibogaine, a plant-based psychoactive drug, reduced symptoms of depression and PTSD in veterans with traumatic brain injuries.
- The study conducted by Stanford University demonstrates significant improvements in cognition and disability rating after taking Ibogaine, suggesting promising results for launching larger trials.
Deep dives
Ibogaine reduces symptoms of PTSD and depression in veterans
A study sponsored by Stanford University tested the effects of the psychoactive drug Ibogaine on 30 special operation veterans with traumatic brain injuries and severe psychiatric symptoms. After taking an oral dose of Ibogaine, the veterans experienced an average reduction of 88% in PTSD symptoms, 87% in depression symptoms, and 81% in anxiety symptoms. The effects lasted for at least a month. Ibogaine, derived from the root bark of the African Iboga shrub, has been used for centuries for spiritual and healing purposes. This study highlights the potential of Ibogaine as a treatment for veterans with treatment-resistant mental illnesses.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
